Speyer, J L <br/><br/>
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 1992 
 - 117-27 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1992.10.1.117  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Doxorubicin--administration & dosage<br/>Female<br/>Heart Failure--chemically induced<br/>Humans<br/>Life Tables<br/>Middle Aged<br/>Razoxane--therapeutic use<br/>Regression Analysis<br/>Survival Analysis<br/>Ventricular Function, Left--drug effects